At present the expression of programmed death-ligand 1 (PD-L1) measured by immunohistochemistry (IHC) on tumor biopsies predicts tumor response to a certain extent, but is not a robust predictor for an individual patient [5]. This evidence concerns the gene CD274 and neoplasm.